Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00318981|
Recruitment Status : Unknown
Verified September 2006 by University of Maryland.
Recruitment status was: Active, not recruiting
First Posted : April 27, 2006
Last Update Posted : September 11, 2006
|Condition or disease||Intervention/treatment||Phase|
|Adult ADHD||Drug: Concerta||Phase 4|
There is evidence to suggest that ADHD persists in approximately 50-65% of individuals diagnosed with the disorder during childhood. Due to the familial nature and presumed genetic etiology of this disorder, parents with ADHD are more likely to have children also diagnosed with ADHD. Accordingly, higher rates of adult ADHD have been found in parents of children with ADHD. Recent research has determined that among children with ADHD, there is a 23 times greater rate of ADHD in mothers and a 4 times greater rate of ADHD in fathers relative to parents of children without the disorder.
Research has also suggested that ADHD symptoms that persist into adulthood are impairing in many areas of an individual’s life, including their family functioning and work functioning. Spouses of ADHD adults report that their partners’ difficulties with communication, task completion, and time management negatively impact their marriages. Similarly, adult ADHD may interfere with parenting in that parents with ADHD may have trouble maintaining their attention during interactions with their children or may overreact to their children’s tantrums. However, the role of parents for children with ADHD is critical. Parents of children with ADHD both assist in the delivery of pharmacological and behavioral treatments their children. Therefore, a parent’s own ADHD symptoms may interfere with their ability to deliver these vital resources to their child.
Despite this research, little research has been conducted looking at effects of using stimulant medication to treat parents with ADHD who have children with ADHD. In fact, only one case study has examined the effects of treatment for parental ADHD on child treatment response.
The current study seeks to examine the effect of a long-acting stimulant medication (Concerta) on mothers with ADHD who have children with ADHD. Mothers and children receive a free comprehensive ADHD assessment and mothers receive a free 7 week treatment of Concerta under the supervision of a physician.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD|
|Study Start Date :||December 2004|
|Study Completion Date :||December 2006|
- Adult ADHD symptoms (Conners Adult ADHD Rating Scale)
- Impairment ratings (CGI)
- Side Effects (Pittsburgh Side Effect Scale)
- Parenting measures (Parenting Stress Index, Alabama Parenting Questionnaire, O'Leary Parenting Scale, Observed Parent Child Interaction)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00318981
|United States, Virginia|
|Children's National Medical Center Regional Outpatient Center|
|Fairfax, Virginia, United States, 22031|
|Principal Investigator:||Andre M Chronis, PhD||University of Maryland, College Park|